Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2025-12-24 @ 12:37 PM
NCT ID:
NCT02784561
Eligibility Criteria:
Inclusion Criteria:
* relapsed/refractory acute leukemia regardless of cytogenetics
* All patients should aged 12 to 65 years
* Have matched sibling donors, ≥8/10 HLA(human leukocyte antigen) matched unrelated donors or haploidentical donors
* Patients without any uncontrolled infections or without severe pulmonary, renal, hepatic or cardiac diseases
Exclusion Criteria:
* Patients aged less than 12 years old
* Patients with any uncontrolled infections or with severe pulmonary, renal, hepatic or cardiac diseases
* Acute myeloid leukemia patients with t (15;17)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
65 Years
Study:
NCT02784561
Study Brief:
Protocol Section:
NCT02784561